Molecular Skincare Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Investors
-
1
Molecular Skincare General Information
Description
Developer of novel dermatology products headquartered in Sheffield, England. The company develops novel treatments for dermatological and allergy-based disorders, such as psoriasis and eczema.
Contact Information
Website
www.molsc.co.ukCorporate Office
- The Innovation Centre
- Sheffield S1 4DP
- England, United Kingdom
Corporate Office
- The Innovation Centre
- Sheffield S1 4DP
- England, United Kingdom
Molecular Skincare Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Feb-2005 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Mar-2002 | Completed | Product Development | |||
| 1. University Spin-Out | 01-Jan-2001 | Completed | Startup |
Molecular Skincare Patents
Molecular Skincare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2003283606-A1 | Psoriasis diagnostics and therapeutics | Inactive | 20-Nov-2002 | ||
| GB-0227026-D0 | Psoriasis diagnostics and therapeutics | Inactive | 20-Nov-2002 | ||
| WO-2004046380-A1 | Psoriasis diagnostics and therapeutics | Inactive | 20-Nov-2002 | ||
| AU-2002350895-A1 | Disease treatment using two related compounds wherein at least one of the compound induces a tachyphylactic response which not affect the other compound | Inactive | 29-Nov-2001 | ||
| WO-2003047594-A1 | Disease treatment using two related compounds wherein at least one of the compound induces a tachyphylactic response which not affect the other compound | Inactive | 29-Nov-2001 | A61K49/0004 |
Molecular Skincare Signals
Molecular Skincare Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Catalyst Biomedica | Corporation | Minority | ||
| Sitka Partners | Venture Capital | Minority | ||
| University of Cambridge | University | Minority |
Molecular Skincare FAQs
-
When was Molecular Skincare founded?
Molecular Skincare was founded in 2001.
-
Where is Molecular Skincare headquartered?
Molecular Skincare is headquartered in Sheffield, United Kingdom.
-
What is the size of Molecular Skincare?
Molecular Skincare has 7 total employees.
-
What industry is Molecular Skincare in?
Molecular Skincare’s primary industry is Drug Discovery.
-
Is Molecular Skincare a private or public company?
Molecular Skincare is a Private company.
-
What is Molecular Skincare’s current revenue?
The current revenue for Molecular Skincare is .
-
How much funding has Molecular Skincare raised over time?
Molecular Skincare has raised $1.89M.
-
Who are Molecular Skincare’s investors?
Catalyst Biomedica, Sitka Partners, and University of Cambridge have invested in Molecular Skincare.
-
When was Molecular Skincare acquired?
Molecular Skincare was acquired on 01-Feb-2005.
-
Who acquired Molecular Skincare?
Molecular Skincare was acquired by York Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process